強気
$8.45
シナリオ価格
$4.170
-0.117 (-2.80%)終値時点
Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution and sale of cannabis and cannabis-derivative products in Canada and internationally. The Company operates through its Cannabis segment. The Cannabis segment comprises the Canadian, Europe, Australian and New Zealand CGUs. The Company offers cannabis products including dried flower, pre-rolls, infused pre-rolls, capsules, cannabis oils, concentrates, vapes, edibles, beverages, and topicals. Its brands include Aurora, MedReleaf, Pedanios, San Raf, WMMC, Tasty's, and others. The Company is engaged in distributing wholesale medical cannabis in various international markets, including Australia and New Zealand. Its subsidiaries include Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, Whistler Medical Marijuana Corporation, and Indica Industries Pty Ltd., and ACB Captive Insurance Company Inc., among others.
Aurora Cannabis Inc is a good buy right now, trading at $4.49, with a recent RSI of 69.36 indicating strong momentum. The stock has seen a 14.54% increase over the past 5 days, suggesting positive short-term momentum. Additionally, the company has a gross margin of 47.68% in its latest quarter, which is significantly higher than previous quarters, indicating improved operational efficiency. However, the main risk is the ongoing hostile takeover bid from Curaleaf, which could lead to volatility in the stock price.
シナリオ価格は本年の最終月次予想レンジです。確率はモデルの固定ウェイト(25 / 50 / 25)であり、保証ではありません。

Aurora Cannabis Rejects Curaleaf's Hostile Bid

Aurora Cannabis Stock Soars Amid Curaleaf Acquisition Bid

Aurora Cannabis Completes Major Facility Expansion in Germany

Aurora Cannabis Responds to Curaleaf's Revised Takeover Bid

Aurora Cannabis Responds to Hostile Takeover Bid
Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution and sale of cannabis and cannabis-derivative products in Canada and internationally. The Company operates through its Cannabis segment. The Cannabis segment comprises the Canadian, Europe, Australian and New Zealand CGUs. The Company offers cannabis products including dried flower, pre-rolls, infused pre-rolls, capsules, cannabis oils, concentrates, vapes, edibles, beverages, and topicals. Its brands include Aurora, MedReleaf, Pedanios, San Raf, WMMC, Tasty's, and others. The Company is engaged in distributing wholesale medical cannabis in various international markets, including Australia and New Zealand. Its subsidiaries include Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, Whistler Medical Marijuana Corporation, and Indica Industries Pty Ltd., and ACB Captive Insurance Company Inc., among others. It operates in the Healthcare sector (MEDICINAL CHEMICALS AND BOTANICAL PRODUCTS industry).
Aurora Cannabis Inc is a good buy right now, trading at $4.49, with a recent RSI of 69.36 indicating strong momentum. The stock has seen a 14.54% increase over the past 5 days, suggesting positive short-term momentum. Additionally, the company has a gross margin of 47.68% in its latest quarter, which is significantly higher than previous quarters, indicating improved operational efficiency. However, the main risk is the ongoing hostile takeover bid from Curaleaf, which could lead to volatility in the stock price.

$ACB Curaleaf is offering about 1.5x sales for this struggling cannabis company. Take the money and shift into the better stock.
もっと見る本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。